Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 10:55 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
2,729,929 4.730% |
-1,062,997 (-28.03%) |
Filing History |
| 2024-01-23 10:52 am Sale |
2023-12-31 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
1,062,951 2.050% |
-69,004 (-6.10%) |
Filing History |
| 2024-01-23 10:50 am Purchase |
2023-12-31 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
1,014,546 1.890% |
210,473 (+26.18%) |
Filing History |
| 2024-01-23 10:47 am Sale |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
STATE STREET CORP STT |
3,870,839 4.820% |
-720,223 (-15.69%) |
Filing History |
| 2024-01-23 10:44 am Purchase |
2023-12-31 | 13G | Embecta Corp. EMBC |
STATE STREET CORP STT |
2,517,076 4.370% |
261,602 (+11.60%) |
Filing History |
| 2024-01-23 10:40 am Sale |
2023-12-31 | 13G | Orion Office REIT Inc. ONL |
STATE STREET CORP STT |
1,650,332 2.960% |
-2,004,642 (-54.85%) |
Filing History |
| 2024-01-23 10:37 am Sale |
2023-12-31 | 13G | 2seventy bio, Inc. TSVT |
STATE STREET CORP STT |
977,590 1.930% |
-91,535 (-8.56%) |
Filing History |
| 2024-01-23 10:34 am Sale |
2023-12-31 | 13G | Design Therapeutics, Inc. DSGN |
STATE STREET CORP STT |
695,224 1.240% |
-2,342,236 (-77.11%) |
Filing History |
| 2024-01-23 10:31 am Sale |
2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
STATE STREET CORP STT |
1,894,279 3.410% |
-951,942 (-33.45%) |
Filing History |
| 2024-01-23 10:28 am Sale |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
STATE STREET CORP STT |
921,322 1.900% |
-1,586,665 (-63.26%) |
Filing History |
| 2024-01-23 10:26 am Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
STATE STREET CORP STT |
1,525,045 1.620% |
-2,154,340 (-58.55%) |
Filing History |
| 2024-01-23 10:22 am Sale |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
STATE STREET CORP STT |
2,619,650 3.640% |
-1,136,039 (-30.25%) |
Filing History |
| 2024-01-23 10:19 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
STATE STREET CORP STT |
1,454,556 4.230% |
-486,167 (-25.05%) |
Filing History |
| 2024-01-23 10:16 am Sale |
2023-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
STATE STREET CORP STT |
5,086,899 2.920% |
-3,758,044 (-42.49%) |
Filing History |
| 2024-01-23 10:13 am Sale |
2023-12-31 | 13G | Verve Therapeutics, Inc. VERV |
STATE STREET CORP STT |
3,866,764 4.810% |
-604,285 (-13.52%) |
Filing History |
| 2024-01-23 10:10 am Sale |
2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
STATE STREET CORP STT |
1,635,726 3.460% |
-871,262 (-34.75%) |
Filing History |
| 2024-01-23 10:07 am Sale |
2023-12-31 | 13G | MDU Resources Group, Inc. MDU |
STATE STREET CORP STT |
10,790,884 2.940% |
-31,855,962 (-74.70%) |
Filing History |
| 2024-01-23 10:02 am Sale |
2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
STATE STREET CORP STT |
2,427,284 1.440% |
-6,739,124 (-73.52%) |
Filing History |
| 2024-01-23 09:59 am Purchase |
2023-12-31 | 13G | Talos Energy Inc. TALO |
STATE STREET CORP STT |
6,159,447 4.960% |
1,483,015 (+31.71%) |
Filing History |
| 2024-01-23 09:54 am Sale |
2023-12-31 | 13G | Adicet Bio, Inc. ACET |
STATE STREET CORP STT |
640,543 1.480% |
-1,644,043 (-71.96%) |
Filing History |